Heterogeneity can predict induction failure in pediatric ALL patients

04/11/2012 | PhysiciansBriefing.com

Children with acute lymphoblastic leukemia who are at risk of induction failure tend to have certain high-risk features, a German study found. Risk factors for induction failure are older age, high leukocyte count, 11q23 rearrangement, T-cell phenotype and Philadephia chromosome, the researchers report in the New England Journal of Medicine. Allogeneic stem-cell transplantation from matched, related donors improved survival in patients with T-cell leukemia, while chemotherapy alone improved survival in children younger than 6 years with precursor B-cell leukemia and no adverse genetic features, the researchers found.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN